Dakota Wealth Management’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.9K Buy
29,000
+3,000
+12% +$5.83K ﹤0.01% 772
2026
Q1
$58K Sell
26,000
-200
-0.8% -$548 ﹤0.01% 762
2025
Q4
$90.7K Buy
+26,200
New +$78.8K ﹤0.01% 771

Other funds holding ANVS

Dakota Wealth Management's ANVS Position: Q2 2026 in Review

Dakota Wealth Management increased its Annovis Bio (ANVS) stake by 12% in Q2 2026, buying an estimated $5.83K and bringing the position to 29,000 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Dakota Wealth Management first reported a position in ANVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $90.7K in Q4 2025. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Dakota Wealth Management held 29,000 shares of Annovis Bio worth $53.9K as of Q2 2026.
  • Dakota Wealth Management bought 3,000 Annovis Bio shares in Q2 2026, an estimated $5.83K.
  • Annovis Bio made up ﹤0.01% of Dakota Wealth Management's portfolio in Q2 2026, its #772 holding.
  • Dakota Wealth Management first reported a position in Annovis Bio in Q4 2025 and has held it in 3 quarters since.
  • Dakota Wealth Management's Annovis Bio position peaked at $90.7K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.